Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activators of CXCR3 for the treatment of angiopathies of the eye

Activators of CXCR3 for the treatment of angiopathies of the eye

US Patent 11406687 · Granted Aug 9, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small peptide compositions and uses thereof2025
Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocul2025
Thermoresponsive hydrogel containing polymer microparticles for controlled drug 2025
Cleavable activators of CXCR3 and methods of use2024
Small peptide compositions and uses thereof2024
Optical Coherence Tomography as a rapid, accurate, non-contact method of visuali2023
Thermoresponsive hydrogel containing polymer microparticles for controlled drug 2022
Small peptide compositions and uses thereof2022
Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocul2022
Image enhancement using virtual averaging2021
Systems and methods for disease progression modeling2021
Optical coherence tomography as a rapid, accurate, non-contact method of visuali2020